Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Hypertension. 2007;50:96-102
Published online before print May 7, 2007, doi: 10.1161/HYPERTENSIONAHA.106.085035
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow All Versions of this Article:
50/1/96    most recent
HYPERTENSIONAHA.106.085035v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Pinaud, F.
Right arrow Articles by Henrion, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Pinaud, F.
Right arrow Articles by Henrion, D.
Related Collections
Right arrow ACE/Angiotension receptors
Right arrow Other Treatment
Right arrow Endothelium/vascular type/nitric oxide
Right arrowRelated Article

(Hypertension. 2007;50:96.)
© 2007 American Heart Association, Inc.


Original Articles

Paradoxical Role of Angiotensin II Type 2 Receptors in Resistance Arteries of Old Rats

Frederic Pinaud; Arnaud Bocquet; Odile Dumont; Kevin Retailleau; Christophe Baufreton; Ramaroson Andriantsitohaina; Laurent Loufrani; Daniel Henrion

From the Centre National de la Recherche Scientifique Unité Mixte de Recherche (CNRS UMR) 6214 (A.B., O.D., K.R., R.A., L.L., D.H.), Institut National de la Santé Et de la Recherche Médicale UMR (INSERM UMR) 771 (A.B., O.D., K.R., R.A., L.L., D.H.), Université d’Angers; and Centre Hospitalier Universitaire d’Angers (F.P., C.B.), Department of Cardiac Surgery and Unité Propre de Recherche de l’Enseignement Supérieur-Equipe Associée 3860, Angers, France.

Correspondence to Daniel Henrion, Department of Neurovascular Integrated Biology, UMR CNRS 6214, INSERM 771, Faculté de Médecine, 49045 Angers, France. E-mail daniel.henrion{at}univ-angers.fr

The role of angiotensin II type 2 receptors (AT2Rs) remains a matter of controversy. Its vasodilatory and antitrophic properties are well accepted. Nevertheless, in hypertensive rats, AT2R stimulation induces a vasoconstriction counteracting flow-mediated dilation (FMD). This contraction is reversed by hydralazine. Because FMD is also decreased in aging, another risk factor for cardiovascular diseases, we hypothesized that AT2R function might be altered in old-rat resistance arteries. Mesenteric resistance arteries (250 µm in diameter) were isolated from old (24 months) and control (4 months) rats receiving hydralazine (16 mg/kg per day; 2 weeks) or water. FMD, NO-mediated dilation, and endothelial NO synthase expression were lower in old versus control rats. AT2R blockade improved FMD in old rats, suggesting that AT2R stimulation produced vasoconstriction. AT2R expression was higher in old rats and mainly located in the smooth muscle layer. In old rats, AT2R stimulation induced endothelium-independent contraction, which was suppressed by the antioxidant Tempol. Reactive oxygen species level was higher in old-rat arteries than in controls. Hydralazine improved FMD and NO-dependent dilation in old rats without change in AT2R expression and location. In old rats treated with hydralazine, reactive oxygen species level was reduced in endothelial and smooth muscle cells, and AT2R-dependent contraction was abolished. Thus, AT2R stimulation induced vasoconstriction through activation of reactive oxygen species production, contributing to decrease FMD in old-rat resistance arteries. Hydralazine suppressed AT2R-dependent reactive oxygen species production and AT2R-dependent contraction, improving FMD. Importantly, endothelial alterations in aging were reversible. These findings are important to consider in the choice of vasoactive drugs in aging.


Key Words: aging • endothelium • microcirculation • angiotensin II receptors • NO • oxidative stress • vasodilator agents


Related Article:

Angiotensin Receptors and Aging
Robert M. Carey
Hypertension 2007 50: 33-34. [Extract] [Full Text] [PDF]



This article has been cited by other articles:


Home page
Pharmacol. Rev.Home page
C. S. Wilcox and A. Pearlman
Chemistry and Antihypertensive Effects of Tempol and Other Nitroxides
Pharmacol. Rev., December 1, 2008; 60(4): 418 - 469.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
D. H. J. Thijssen, G. A. Rongen, P. Smits, and M. T. E. Hopman
Physical (in)activity and endothelium-derived constricting factors: overlooked adaptations
J. Physiol., January 15, 2008; 586(2): 319 - 324.
[Abstract] [Full Text] [PDF]